Browse by Person

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Item Type | Date | No Grouping
Number of items: 46.


Snijder, C.A., Kortenkamp, A., Steegers, E.A.P., Jaddoe, V.W.V., Hofman, A., Hass, U. and Burdorf, A. (2012) Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study. Human Reproduction, 27 (4). pp. 1191-1201. 10.1093/humrep/der474.

Silva, E., Rajapakse, N., Scholze, M., Backhaus, T., Ermler, S. and Kortenkamp, A. (2011) Joint effects of heterogeneous estrogenic chemicals in the E-Screen - exploring the applicability of concentration addition. Toxicological Sciences . 10.1093/toxsci/kfr103.

Kortenkamp, A. (2011) Are cadmium and other heavy metal compounds acting as endocrine disrupters? Metal Ions in Life Sciences, 8 . pp. 305-317.

Modarai, M., Silva, E., Suter, A., Heinrich, M. and Kortenkamp, A. (2011) Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides do not Induce CYP3A4 mRNA Expression. Evidence-Based Complementary and Alternative Medicine, 2011 (213021.). 10.1093/ecam/nep174..

Modarai, M., Suter, A., Kortenkamp, A. and Heinrich, M. (2011) The interaction potential of herbal medicinal prodicts: a luminescence-based screening platform assessing effects on cytochrome P-450 and its use with Devil's Claw (Harpagophyti radix) preparations. Journal of Pharmacy and Pharmacology, 63 (3). pp. 429-438. 10.1111/j.2042-7158.2010.01235.x.

Orton, F., Rosivatz, E., Scholze, M. and Kortenkamp, A. (2011) Widely used pesticides with previously unknown endocrine activity revealed as in vitro antiandrogens. Environmental Health Perspectives, 119 (6). pp. 794-800. 10.1289/ehp.1002895.

Evans, R.M., Rahte, S. and Kortenkamp, A. (2010) Inability to confirm estrogenicity of the heterocyclic amine PhIP in two in vitro assays. Toxicology in Vitro, 24 (6). pp. 1757-1763. 10.1016/j.tiv.2009.12.017 .

Ermler, S., Scholze, M. and Kortenkamp, A. (2010) The sensitivity of the MDA-kb2 cell in vitro assay in detecting anti-androgenic chemicals - identification of sources of variability and estimation of statistical power. Toxicology in Vitro, 24 (6). pp. 1845-1853. 10.1016/j.tiv.2010.05.007 .

Silva, E., Kabil, A. and Kortenkamp, A. (2010) Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicology and Applied Pharmacology, 245 (2). pp. 160-170. 10.1016/j.taap.2010.02.015 .

Kortenkamp, A. and Faust, M. (2010) Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment. International Journal Of Andrology, 33 (2). pp. 463-474. 10.1111/j.1365-2605.2009.01047.x.

Modarai, M., Yang, M., Suter, A., Kortenkamp, A. and Heinrich, M. (2010) Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4). Planta Medica, 76 (4). pp. 378-385. 10.1055/s-0029-1186152.

Heinrich, M., Modarai, M. and Kortenkamp, A. (2008) Herbal extracts used for upper respiratory tract infections: are there clinically relevant interactions with the Cytochrome P450 enzyme system? Planta Medica, 74 (5). pp. 657-660. 10.1055/s-2008-1034292.

Kortenkamp, A. (2008) Breast cancer and environmental risk factors: an appraisal of the scientific evidence. Breast Cancer Research, 10 (Suppl 2). P45. 10.1186/bcr1929.

Modarai, M., Suter, A., Kortenkamp, A. and Heinrich, M. (2008) CYP3A4 inhibitory compounds from Echinacea extract (Echinaforce). Planta Medica, 74 (9). 10.1055/s-0028-1084478.

Kabil, A., Silva, E. and Kortenkamp, A. (2008) Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals. Carcinogenesis, 29 (10). pp. 1862-1868. 10.1093/carcin/bgn138.

Kortenkamp, A. (2008) Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. International Journal Of Andrology, 31 (2). pp. 233-240. 10.1111/j.1365-2605.2007.00862.x.

Modarai, M., Gertsch, J., Suter, A., Heinrich, M. and Kortenkamp, A. (2007) Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. Journal of Pharmacy and Pharmacology, 59 (4). pp. 567-573. 10.1211/jpp.59.4.0012.

Silva, E., Scholze, M. and Kortenkamp, A. (2007) Activity of xenoestrogens at nanomolar concentrations in the E-Screen assay. Environmental Health Perspectives, 115 Suppl 1 . pp. 91-97. 10.1289/ehp.9363.

Kortenkamp, A. (2007) Introduction: Endocrine Disruptors-Exposure Assessment, Novel End Points, and Low-Dose and Mixture Effects. Environmental Health Perspectives, 115 (S-1). p. 7. 10.1289/ehp.10517..

Kortenkamp, A., Faust, M., Scholze, M. and Backhaus, T. (2007) Low-level exposure to multiple chemicals: reason for human health concerns? Environmental Health Perspectives, 115 (Suppl 1). pp. 106-114. 10.1289/ehp.9358..

Scholze, M. and Kortenkamp, A. (2007) Statistical power considerations show the endocrine disruptor low-dose issue in a new light. Environmental Health Perspectives, 115 (Suppl 1). pp. 84-90. 10.1289/ehp.9364.

Kortenkamp, A. (2007) Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environmental Health Perspectives, 115 (Suppl 1). pp. 98-105. 10.1289/ehp.9357.

Kortenkamp, A. (2006) Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective. International Journal Of Andrology, 29 (1). pp. 193-198. 10.1111/j.1365-2605.2005.00613.x.

Silva, E., Lopez-Espinosa, M.J., Molina-Molina, J-M., Fernández, M., Olea, N. and Kortenkamp, A. (2006) Lack of activity of cadmium in in vitro estrogenicity assays. Toxicology and Applied Pharmacology, 216 (1). pp. 20-28. 10.1016/j.taap.2006.04.002.

Rajapakse, N., Butterworth, M. and Kortenkamp, A. (2005) Detection of DNA strand breaks and oxidized DNA bases at the single-cell level resulting from exposure to estradiol and hydroxylated metabolites. Environmental and Molecular Mutagenesis, 45 (4). pp. 397-404. 10.1002/em.20104.

Rajapakse, N., Silva, E., Scholze, M. and Kortenkamp, A. (2004) Deviation from additivity with estrogenic mixtures containing 4-nonylphenol and 4-tert-octylphenol detected in the E-SCREEN assay. Environmental Science & Technology, 38 (23). pp. 6343-6352. 10.1021/es049681e.

Tang, S., Schlage, C., Kortenkamp, A., Gray, A., Gibbons, S. and Heinrich, M. (2003) Bioflavonoids with cytotoxic and immunomodulatory activity from Ohna macrocalyx. Planta Medica, 69 (3). pp. 247-253. 10.1055/s-2003-38478.

Tang, S., Bremner, P., Kortenkamp, A., Schlage, C., Gray, A.I., Gibbons, S. and Heinrich, M. (2003) Biflavonoids with Cytotoxic and Antibacterial Activity fromOchna macrocalyx. Planta Medica, 69 (3). pp. 247-253. 10.1055/s-2003-38478.

Rajapakse, N., Silva, E. and Kortenkamp, A. (2002) Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environmental Health Perspectives, 110 (9). pp. 917-921.

Silva, E., Rajapakse, N. and Kortenkamp, A. (2002) Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environmental Science & Technology, 36 (8). pp. 1751-1756. 10.1021/es0101227.

Rajapakse, N., Ong, D. and Kortenkamp, A. (2001) Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicological Sciences, 60 (2). pp. 296-304. 10.1093/toxsci/60.2.296.

Payne, J., Scholze, M. and Kortenkamp, A. (2001) Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environmental Health Perspectives, 109 (4). pp. 391-397.

Payne, J, Jones, C, Lakhani, S and Kortenkamp, A. (2000) Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens. Science of the Total Environment, 248 (1). pp. 51-62. 10.1016/S0048-9697(99)00479-9.

Payne, J., Rajapakse, N., Wilkins, M. and Kortenkamp, A. (2000) Prediction and assessment of the effects of mixtures of four xenoestrogens. Environmental Health Perspectives, 108 (10). pp. 983-987.

Jones, C. and Kortenkamp, A. (2000) RAPD library fingerprinting of bacterial and human DNA: applications in mutation detection. Teratogenesis, Carcinogenesis, and Mutagenesis, 20 (2). pp. 49-63. 10.1002/(SICI)1520-6866(2000)20:2<49::AID-TCM1>3.0.CO;2-D.

Kortenkamp, A. and Altenburger, R. (1999) Approaches to assessing combination effects of oestrogenic environmental pollutants. Science of the Total Environment, 233 (1-3). pp. 131-140. 10.1016/S0048-9697(99)00228-4.

Casadevall, M., da Cruz Fresco, P. and Kortenkamp, A. (1999) Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites. Chemico-Biological Interactions, 123 (2). pp. 117-132. 10.1016/S0009-2797(99)00128-3.

Kortenkamp, A. and Altenburger, R. (1998) Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles. Science of the Total Environment, 221 (1). pp. 59-73. 10.1016/S0048-9697(98)00261-7.

Kortenkamp, A., Jones, C. and Baker, J. (1997) Genotypic selection of mutated DNA sequences using mismatch cleavage analysis, a possible basis for novel mutation assays. Mutagenesis, 12 (5). pp. 335-338. 10.1093/mutage/12.5.335.

Kortenkamp, A., Casadevall, M., Faux, S.P., Jenner, A., Shayer, R.O., Woodbridge, N. and O'Brien, P. (1996) A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione. Archives of Biochemistry and Biophysics, 329 (2). pp. 199-207. 10.1006/abbi.1996.0209.

Kortenkamp, A. (1996) Pharmacokinetic modelling in chromium risk assessment. Human and Experimental Toxicology, 15 (7). pp. 601-602.

da Cruz Fresco, P., Shacker, F. and Kortenkamp, A. (1995) The reductive conversion of chromium (VI) by ascorbate gives rise to apurinic/apyrimidinic sites in isolated DNA. Chemical Research in Toxicology, 8 (6). pp. 884-890. 10.1021/tx00048a009.

da Cruz Fresco, P. and Kortenkamp, A. (1994) The formation of DNA cleaving species during the reduction of chromate by ascorbate. Carcinogenesis, 15 (9). pp. 1773-1778. 10.1093/carcin/15.9.1773 .

Casadevall, M. and Kortenkamp, A. (1994) The generation of apurinic/apyrimidinic sites in isolated DNA during the reduction of chromate by glutathione. Carcinogenesis, 15 (2). pp. 407-409. 10.1093/carcin/15.2.407.

Kortenkamp, A. and O'Brien, P. (1994) The generation of DNA single-strand breaks during the reduction of chromate by ascorbic acid and/or glutathione in vitro. Environmental Health Perspectives, 102 Suppl 3 . pp. 237-241.

Kortenkamp, A., Curran, B. and O'Brien, P. (1992) Defining conditions for the efficient in vitro cross-linking of proteins to DNA by chromium(III) compounds. Carcinogenesis, 13 (2). pp. 307-308.

This list was generated on Sat May 30 05:33:11 2015 BST.